The apoptosis index (Figure 2A, 2B) was increased and the expression of key proliferation markers cyclin D1 and c-Myc were downregulated in test colon tumors, providing good in vivo molecular evidence for the antiproliferative efficacy and associated antitumor activities. Here, MYC is linked to colonic neoplasm.